Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-07-19
2011-07-19
Audet, Maury (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S001690, C530S331000, C514S015100
Reexamination Certificate
active
07981858
ABSTRACT:
The present invention provides zinc complexes for use in methods of providing zinc to subjects in need of treatment. The invention further provides improved dietary supplement formulations for improving and maintaining ocular nutrition. In particular, the improved dietary supplement formulations comprise the zinc complexes described herein, antioxidant vitamins, minerals and excipients.
REFERENCES:
patent: 3998753 (1976-12-01), Antoshkiw et al.
patent: 4254100 (1981-03-01), Keller et al.
patent: 4670247 (1987-06-01), Scialpi
patent: 5156852 (1992-10-01), LaHaye et al.
patent: 6573299 (2003-06-01), Petrus
patent: 6582721 (2003-06-01), Lang
patent: 6586611 (2003-07-01), Newsome et al.
patent: 6716447 (2004-04-01), Lang
patent: 2006/0134226 (2006-06-01), Leonard
Alexander et al. Acta Pharmacol Toxicol (Copenh). Sep. 1981;49(3):190-4).
Bae et al. Characteristics of glutathione-capped ZnS nanocrystallites. Biochemical and Biophysical Research Communications. vol. 237, Issue 1, Aug. 8, 1997, pp. 16-23.
Nishimura et al. L-carnosine and close derivatives accelerate zinc update from the intestine in rats. Biomed Res. Trace Elements, 12(2): 159:167, 2001 (Table 5, GSH-Zn).
Alexander et al.; “Excretion of zinc in rat bile—a role of glutathione”; Acta Pharmacol., et. Toxicol.; vol. 49; pp. 190-194 (1981).
Fur and Rabenstein; “Nuclear magnetic resonance studies of the solution chemistry of metal complexes. IX. The binding of cadmium, zinc, lead, and mercury by glutathione”; Journal of the American Chemical Society; vol. 95; No. 21; pp. 6944-6950 (Oct. 17, 1973).
Li et al.; “Stability of zinc complexes with glutathione and oxidized glutathione”; JACS; vol. 76; pp. 225-229; (Jan. 5, 1954).
Newsome et al.; “Oral zinc in macular degeneration”; Arch. Ophthalmol. vol. 106; pp. 192-198 (Feb. 1988).
Nishimura et al; “L-carnosine and close derivatives accelerate zinc uptake form the intestine in rats”; Biomed. Res. Trace Elements; vol. 12; No. 2; pp. 159-167 (2001).
Perrin and Watt; “Complex formation of zinc and cadmium with glutathione”; Biochim. Biophys. Acta; vol. 230; pp. 96-104 (1971).
Sato et al; “The distribution and binding of zinc in the hippocampus”; The Journal of Neuroscience; vol. 4; No. 6; pp. 1662-1670 (Jun. 1984).
Sato et al; “A kinetic study of the in vivo incorporation of 65ZN into the rat hippocampus”; The Journal of Neuroscience; vol. 4; No. 6; pp. 1671-1675 (Jun. 1984).
Alcon Inc.
Audet Maury
Schultz Teresa J.
LandOfFree
Methods of using zinc containing compounds to improve ocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using zinc containing compounds to improve ocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using zinc containing compounds to improve ocular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696737